References
Kontogeorgos G, Watson Jr. RE, Lindell EP, Barkan AL, Farrell WE, Lloyd RV. Growth hormone producing adenoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization Classification of Tumours. IARC, Lyon: 14–9, 2004.
Horvath E, Kovacs K. Morphogenesis and significance of fibrous bodies in human pituitary adenomas. Virchows Arch B Cell Pathol 27: 69–78, 1978.
Neumann P, Goldman J, Horoupian D, HESS M. Fibrous bodies in growth hormone-secreting adenomas contain cytokeratin filaments. Arch Pathol Lab Med 109: 505–8, 1985.
Sano T, Yamada S, Hirose T, Hizawa K. Cytokeratin distribution and functional properties of growth hormone-producing pituitary adenomas. Endocr Pathol 5: 107–13, 1994.
Kreutzer J, Vance M, Lopes M, Laws E. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 86: 4072–7, 2001.
Bhayana S, Booth GL, Asa SL, Kovacs K, Ezzat S. The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab 90: 6290–5, 2005.
Obari A, Sano T, Ohyama K, Kudo E, Qian ZR, Yoneda A, Rayhan N, Mustafizur Rahman M, Yamada S. Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 19: 82–91, 2008.
Lonser RR, Kindzelski BA, Mehta GU, Jane JA, Oldfield EH. Acromegaly without imaging evidence of pituitary adenoma. J Clin Endocrinol Metab 95: 4192–6, 2010.
Daud S, Hamrahian AH, Weil RJ, Hamaty M, Prayson RA, Olansky L. Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration? Pituitary 14: 414–7, 2011.
Weiss RE. Empty sella following spontaneous resolution of a pituitary macroadenoma. Horm Res 60: 49–52, 2003.
Coulson CJ, Siddiq MA, Johnson AP. Empty sella syndrome associated with a hyperfunctioning microadenoma invating the clivus. Br J Neurosurg 21: 623–25, 2007.
Yamada S, Aiba T, Sano T, Kovacs K, Shishiba Y, Sawano S, Takada K. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology. Neurosurgery 33: 20–7, 1993.
Fougner SL, Lekva T, Borota OC, Hald JK, Bollerslev J, Berg JP. The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response. J Clin Endocrinol Metab 95: 2334–42, 2010.
Fougner SL, Casar-Borota O, Heck A, Berg JP, Bollerslev J. Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol (Oxf) 76: 96–102, 2012.
Horvath E, Kovacs K, Scheithauer BW. Pituitary Hyperplasia. Pituitary 1: 169–80, 1999.
Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 86: 2779–86. 2001.
Acknowledgments
This work was supported, in part, by Health and Labour Science Research Grants (Research on Measures for Intractable Diseases) from the Ministry of Health, Labour, and Welfare of Japan.
Conflicts of interest
The authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamagata, S., Kageyama, K., Sakihara, S. et al. Unusual Type of Growth Hormone-Producing Pituitary Tumor in Acromegaly. Endocr Pathol 23, 201–204 (2012). https://doi.org/10.1007/s12022-012-9210-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-012-9210-2